Short, or daily, dosing of PTH directs osteoblasts to form new cortical bone, while constitutive PTH dosing—exhibited in hyperparathyroidism—drives catabolic osteoclast resorption [73]. This evidence concerns the gene PTH and hyperparathyroidism.